Flibanserin CAS:167933-07-5 cheryl@chembj.com

• Post Date:

  Dec 31,2015

• Expiry Date:

  Dec 30,2016

• Detailed Description:

  Quantity: 3000Kilograms
  Specs:cheryl@chembj.com
  Price:1 USD Kilograms
  Payment Method: T/T , Moneygram , Westunion,Bitcoin
  Female Sex Enhancement Powder Flibanserin CAS:167933-07-5
  Women Sexual Desire Disorder Flibanserin CAS:167933-07-5
  
  Flibanserin CAS:167933-07-5
  Molecular formula: C20H21F3N4O
  Molecular weight: 390.4
  purity: 99%
  Appearance: White powder
  Grade: Pharmaceutical grade
  Usage:adrug being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder
  Catagory: Pharmaceutical raw material female sex enhance
  
  Introduction:HSDD is the most commonly reported form of female sexual dysfunction. HSDD is defined as a persistent or recurrent deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty, and which is not better accounted for by a medical, substance-related, psychiatric (e.g., depression) or other sexual condition. The cause of HSDD is believed to involve a multitude of social, psychological and biological factors and may be attributed to a complex interplay of these factors.
  
  Applications: A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but it's hit a potentially serious snag. The drug didn't boost women's desire any more than a placebo in two clinical trials.
  
  The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels. ) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn't "particularly compelling.
  
  It's called the "little pink pill, " a tiny tablet that could have a huge impact on treating female sexual dysfunction. If it's approved, it would become the first drug of its kind on the market.
  

• Company:

  Hubei Yuancheng Saichuang Technology Co., Ltd     [ China ]        

• Contact:

  Cheryl

• Tel:

  8618771024715

• Fax:

• Email:

  cheryl@chembj.com